Conceptio
›
fatty-liver
Topic
fatty-liver
Knowledge-graph topic
· documents ABOUT fatty-liver across the archive
89
Documents about fatty-liver
Documents about fatty-liver
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
#855660
ClinicalTrials.gov
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
#979737
ClinicalTrials.gov
Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model
#143723
ClinicalTrials.gov
P465L-PPARγ mutation confers partial resistance to the hypolipidemic action of fibrates
#213180
HAL (France)
Lyophilized strawberry meal mitigates hepatic lipid accumulation in a mouse model of diet-induced obesity
#280605
IBISS
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
#411309
ClinicalTrials.gov
High Fructose Diet, the Gut Microbiome, and Metabolic Health
#801829
ClinicalTrials.gov
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
#837842
ClinicalTrials.gov
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation
#849419
ClinicalTrials.gov
Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD
#854107
ClinicalTrials.gov
Endobarrier Treatment in Obese Subjects With T2DM
#877914
ClinicalTrials.gov
Multimodal Approach in IBD Patients
#879936
ClinicalTrials.gov
Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery
#910025
ClinicalTrials.gov
<b>Visit-to-visit variability in body weight and lipid parameters and the risk of metabolic dysfunction-associated steatotic liver disease in the general population</b>
#300611
Figshare
Potential Association of a Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance
#968523
ClinicalTrials.gov
A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus
#642093
eScholarship
Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight
#160220
ClinicalTrials.gov
Water extract of Artemisia capillaris alleviates fatty liver hemorrhagic syndrome in laying hens by modulating the gut microbiota-bile acid axis.
#170675
NCBI PubMed Central
Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review)
#273252
Europe PMC
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease
#274089
HAL (France)
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
#325236
ClinicalTrials.gov
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
#801679
ClinicalTrials.gov
Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort
#812772
ClinicalTrials.gov
Hepatoprotective Measures for Children at High Risk of NAFLD
#838623
ClinicalTrials.gov
Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease
#855595
ClinicalTrials.gov
Associations between source-specific nitrate and nitrite intakes and metabolic dysfunction-associated steatotic liver disease in two prospective cohorts
#197594
Research Online
Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study.
#138541
NCBI PubMed Central
[Key determinants of global burden of non-alcoholic fatty liver disease: machine learning combined with Mendelian randomization analysis based on GBD data].
#143174
NCBI PubMed Central
Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon
#343733
ClinicalTrials.gov
Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis
#447649
USM Repository
Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants
#829736
ClinicalTrials.gov
Short Term Intermittent Fasting and Insulin Resistance
#841395
ClinicalTrials.gov
Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?
#860526
ClinicalTrials.gov
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function
#874478
ClinicalTrials.gov
Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation
#907294
ClinicalTrials.gov
Exercise dose on hepatic fat and cardiovascular health in adolescents with excess of adiposity
#935838
Repositorio de Universidad Autónoma de Chile.
The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study
#994116
ClinicalTrials.gov
A study of the protective effects of an aspalathin enriched green rooibos extract on experimentally induced hepatic steatosis
#1024429
UZSpace
In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease
#780484
eScholarship
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
#141198
ClinicalTrials.gov
Inverse Association Between Dietary Niacin Intake and Prevalence of Depressive Symptoms in Adults With Metabolic‐Associated Fatty Liver Disease: A Cross‐Sectional Study.
#297473
NCBI PubMed Central
Microbiota-Derived Indole-3-Carboxaldehyde Exerts Sex-Specific Protective Effects in a Reverse Translational Mouse Model of Diet-Induced Obesity and Fatty Liver Disease
#326384
IBISS
Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD
#860207
ClinicalTrials.gov
A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.
#862394
ClinicalTrials.gov
Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia
#891863
ClinicalTrials.gov
To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation
#1009686
ClinicalTrials.gov
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
#846047
ClinicalTrials.gov
Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)
#911479
ClinicalTrials.gov
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
#968053
ClinicalTrials.gov
Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism
#143880
PLOS
← Previous
Page 8 of 9
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.